DHA‐Enriched Phosphatidylcholine and DHA‐Enriched Phosphatidylserine Improve Age‐Related Lipid Metabolic Disorder through Different Metabolism in the Senescence‐Accelerated Mouse
- 24 March 2018
- journal article
- research article
- Published by Wiley in European Journal of Lipid Science and Technology
- Vol. 120 (6)
Abstract
Aging is an independent risk factor for the development of atherosclerosis, which is characterized by hyperlipemia. The senescence‐accelerated mouse (SAMP8) is an animal model used in studies of aging, which is associated with a shift of fatty metabolism toward lipogenesis. This study investigates the effects of docosahexaenoic acid‐enriched phosphatidylcholine (DHA‐PC) and docosahexaenoic acid‐enriched phosphatidylserine (DHA‐PS) on age‐related lipid metabolic disorder in SAMP8 mice. Main findings and results: Both dietary DHA‐PC and DHA‐PS significantly decrease serum and hepatic lipid levels. The levels of DHA in hepatic total lipid are significantly increased in both DHA‐PC and DHA‐PS groups (2.59‐ and 2.33‐fold, respectively). Notably, supplementary DHA‐PS remarkably alters the ratio of PE to PC in liver. Mechanistically, DHA‐PC and DHA‐PS suppresses hepatic SREBP‐1c mediates lipogenesis and activates PPARα mediated fatty acid β‐oxidation in the liver. These data are the first to indicate that DHA‐PS has beneficial effects on age‐related lipid metabolism.Practical Applications: The results obtained in this work might contribute to the understanding of biological activities of DHA enriched phospholipids and further investigation on its potential application values for food supplements.This study investigates the effects of docosahexaenoic acid‐enriched phosphatidylcholine (DHA‐PC) and docosahexaenoic acid‐enriched phosphatidylserine (DHA‐PS) on age‐related lipid metabolic disorder in SAMP8 mice. The results shows that DHA‐PC and DHA‐PS improves age‐related lipometabolic disturbance by inhibiting hepatic fatty acid synthesis and enhancing hepatic fatty acid β‐oxidation, providing a reference for the development of functional ingredients rich in DHA phospholipids.Keywords
Funding Information
- National Natural Science Foundation of China (U1606403)
- National Natural Science Foundation of China (31330060)
- National Natural Science Foundation of China (31371757)
This publication has 37 references indexed in Scilit:
- Association studies of several cholesterol-related genes (ABCA1, CETP and LIPC) with serum lipids and risk of Alzheimer’s diseaseLipids in Health and Disease, 2012
- A novel omega-3 free fatty acid formulation has dramatically improved bioavailability during a low-fat diet compared with omega-3-acid ethyl esters: The ECLIPSE (Epanova® compared to Lovaza® in a pharmacokinetic single-dose evaluation) studyJournal of Clinical Lipidology, 2012
- Metabolic Effects of n-3 PUFA as Phospholipids Are Superior to Triglycerides in Mice Fed a High-Fat Diet: Possible Role of EndocannabinoidsPLOS ONE, 2012
- LIPID PROFILE AND FATTY ACID COMPOSITIONS IN BODY WALL OF APOSTICHOPUS JAPONICUS (SELENKA)Journal of Food Biochemistry, 2011
- Omega-3 fatty acids and metabolic syndrome: Effects and emerging mechanisms of actionProgress in Lipid Research, 2011
- Incorporation of EPA and DHA into plasma phospholipids in response to different omega-3 fatty acid formulations - a comparative bioavailability study of fish oil vs. krill oilLipids in Health and Disease, 2011
- Endogenous ligand for an orphan receptor2010
- Quantification of major lipid classes in human triacylglycerol‐rich lipoproteins by high‐performance liquid chromatography with evaporative light‐scattering detectionJournal of Separation Science, 2004
- SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liverJournal of Clinical Investigation, 2002
- Intestinal Absorption of Polyunsaturated Phosphatidylcholine in the RatHoppe-Seyler´s Zeitschrift Für Physiologische Chemie, 1976